CLOSTRIDIUM; SEPSIS

Clinical trials for CLOSTRIDIUM; SEPSIS explained in plain language.

Never miss a new study

Get alerted when new CLOSTRIDIUM; SEPSIS trials appear

Sign up with your email to follow new studies for CLOSTRIDIUM; SEPSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Promising c. diff drug fails to prove benefit in small, halted trial

Disease control Terminated

This study tested whether an extra dose of bezlotoxumab, a drug that blocks the harmful toxin made by C. diff bacteria, could help very sick patients recover after emergency colon surgery. Only 5 people took part before the study was stopped early. The goal was to see if the drug…

Matched conditions: CLOSTRIDIUM; SEPSIS

Phase: PHASE4 • Sponsor: Ohio State University • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

CLOSTRIDIUM; SEPSIS

Get alerted when new CLOSTRIDIUM; SEPSIS trials appear

Promising c. diff drug fails to prove benefit in small, halted trial